Intercept Pharmaceuticals

Intercept Pharmaceuticals is a biopharmaceutical company dedicated to the discovery and development of small molecule drugs for the treatment of chronic fibrotic and metabolic diseases. It provides a FXR modulator called INT-747, which can treat patients with chronic autoimmune liver disease. The company's drug development programs also focus on modulating bile acid receptors to improve metabolism and liver function in chronic liver diseases.